{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:16:13Z","timestamp":1777439773256,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T00:00:00Z","timestamp":1170806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Apoptosis in the liver is generated mainly by the Fas system. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has been proposed recently as a new apoptotic inducer. In the liver environment hepatocytes and biliary epithelial cells express TRAIL receptors which are up-regulated by increased levels of bile acids and during viral hepatitis. As for FasL, a soluble form of TRAIL has been described. To explore the commitment and level of activation of these two apoptotic systems in patients affected by primary biliary cirrhosis (PBC) or chronic hepatitis C (CH-C), a comparative study was drawn. Thirty patients with PBC on ursodeoxycholic acid have been enrolled. This group was compared with 30 patients with CH-C and with 20 healthy subjects. Soluble Fas ligand (sFasL) and soluble TRAIL (sTRAIL) levels were evaluated by double determinant immune assay and enzyme-linked immunosorbent assay (ELISA), respectively. Soluble FasL molecules were higher in PBC compared to CH-C (P\u2003=\u20030\u00b7009). Soluble FasL was not detected in controls. Soluble TRAIL was significantly higher in CH-C patients compared to PBC (P\u2003=\u20030\u00b70001). Soluble TRAIL levels were higher in PBC and in CH-C than in controls (P\u2003=\u20030\u00b7015 and P\u2003&amp;lt;\u20030\u00b7001, respectively). No correlation between sFasL and sTRAIL, stage of disease, liver histology in each disease and cytolysis was present. Our data show different levels of commitment of TRAIL and Fas apoptosis-inducing systems in CH-C and PBC. Thus a different prominent role of TRAIL and Fas systems in the pathogenesis of these two conditions can be speculated: the former by inducing the death of infected hepatocytes, the latter by mediating the disappearance of bile duct.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2006.03293.x","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T19:17:10Z","timestamp":1281035830000},"page":"85-89","source":"Crossref","is-referenced-by-count":18,"title":["Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C"],"prefix":"10.1093","volume":"148","author":[{"given":"N","family":"Pelli","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Floreani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"},{"name":"Department of Surgical and Gastroenterological Science, University of Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Torre","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Delfino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Baragiotta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"},{"name":"Department of Surgical and Gastroenterological Science, University of Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Contini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Basso","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Picciotto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,2,14]]},"reference":[{"key":"2022010414514797300_b1","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1111\/j.1572-0241.2000.03327.x","article-title":"Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activity","volume":"95","author":"Gozlan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2022010414514797300_b2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.510260604","article-title":"Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis","volume":"26","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"2022010414514797300_b3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0676.1998.tb00166.x","article-title":"Cell-kinetic study of proliferating bile ductules in various hepatobiliary diseases","volume":"18","author":"Harada","year":"1998","journal-title":"Liver"},{"key":"2022010414514797300_b4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/hep.510250505","article-title":"Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis","volume":"25","author":"Koga","year":"1997","journal-title":"Hepatology"},{"key":"2022010414514797300_b5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0106-9543.2002.01595.x","article-title":"Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"22","author":"Tinmouth","year":"2002","journal-title":"Liver"},{"key":"2022010414514797300_b6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI4765","article-title":"Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas","volume":"103","author":"Faubion","year":"1999","journal-title":"J Clin Invest"},{"key":"2022010414514797300_b7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nm0198-021","article-title":"Fas ligand\u2003\u2212\u2003caught between Scylla and Charybdis","volume":"4","author":"Strasser","year":"1998","journal-title":"Nat Med"},{"key":"2022010414514797300_b8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08923970009016403","article-title":"sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology","volume":"22","author":"Tortorella","year":"2000","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2022010414514797300_b9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI200419255","article-title":"Critical roles of TRAIL in hepatic cell death and hepatic inflammation","volume":"113","author":"Zheng","year":"2004","journal-title":"J Clin Invest"},{"key":"2022010414514797300_b10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"2022010414514797300_b11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1369\/jhc.3A6112.2004","article-title":"Tissue distribution of the death ligand TRAIL and its receptors","volume":"52","author":"Spierings","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"2022010414514797300_b12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.M309476200","article-title":"Bile acids up-regulate death receptor 5\/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1","volume":"279","author":"Higuchi","year":"2004","journal-title":"J Biol Chem"},{"key":"2022010414514797300_b13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0168-8278(03)00265-4","article-title":"Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1\/death receptor 4 expression","volume":"39","author":"Janssen","year":"2003","journal-title":"J Hepatol"},{"key":"2022010414514797300_b14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1096\/fj.02-0537fje","article-title":"Involvement of TRAIL and its receptors in viral hepatitis","volume":"17","author":"Mundt","year":"2003","journal-title":"FASEB J"},{"key":"2022010414514797300_b15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"2022010414514797300_b16","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1158\/0008-5472.CAN-04-2599","article-title":"TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice","volume":"64","author":"Hao","year":"2004","journal-title":"Cancer Res"},{"key":"2022010414514797300_b17","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.168.10.4881","article-title":"Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells","volume":"168","author":"Lunemann","year":"2002","journal-title":"J Immunol"},{"key":"2022010414514797300_b18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2006.26.119","article-title":"Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C","volume":"26","author":"Pelli","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"2022010414514797300_b19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2004.0906.x","article-title":"Apoptosis and necrosis in liver disease","volume":"24","author":"Jaeschke","year":"2004","journal-title":"Liver Int"},{"key":"2022010414514797300_b20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0676.2001.021004272.x","article-title":"Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis","volume":"21","author":"Fox","year":"2001","journal-title":"Liver"},{"key":"2022010414514797300_b21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.163.2.920","article-title":"IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression","volume":"163","author":"Sedger","year":"1999","journal-title":"J Immunol"},{"key":"2022010414514797300_b22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3748\/wjg.v8.i6.1077","article-title":"Detection of soluble TRAIL in HBV infected patients and its clinical implications","volume":"8","author":"Han","year":"2002","journal-title":"World J Gastroenterol"},{"key":"2022010414514797300_b23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/jpet.102.040030","article-title":"Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2\/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity","volume":"303","author":"Higuchi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"2022010414514797300_b24","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J Clin Invest"},{"key":"2022010414514797300_b25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2893.2003.00452.x","article-title":"Apoptosis in hepatitis C","volume":"10","author":"Kountouras","year":"2003","journal-title":"J Viral Hepatol"},{"key":"2022010414514797300_b26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"2022010414514797300_b27","volume-title":"Diseases of the liver and biliary system","author":"Sherlock","year":"2002","edition":"11th"},{"key":"2022010414514797300_b28","first-page":"400","article-title":"Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults","volume":"34","author":"Choi","year":"2004","journal-title":"Ann Clin Lab Sci"},{"key":"2022010414514797300_b29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2005.08.004","article-title":"Associations of Fas (CD95), tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), and biochemical manifestations in elderly persons","volume":"365","author":"Choi","year":"2006","journal-title":"Clin Chim Acta"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2006.03293.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/148\/1\/85\/42054516\/j.1365-2249.2006.03293.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/148\/1\/85\/42054516\/j.1365-2249.2006.03293.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T16:54:18Z","timestamp":1685724858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/148\/1\/85\/6457833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,2,14]]},"published-print":{"date-parts":[[2007,2,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03293.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,4]]},"published":{"date-parts":[[2007,2,7]]}}}